Electrochemical properties of biomolecular condensates could help in development of cancer or ALS treatments
Much of cell behavior is governed by the actions of biomolecular condensates: building block molecules that glom together and scatter apart as needed. Biomolecular condensates constantly shift their ...
Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
ALS News Today19h
Legislation seeks access to benefits for spouses of veterans with ALS
Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight years before dying.
IEEE Spectrum on MSN20h
New Brain Tech Gives Voice to ALS Patients
A myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...